Building capacity for clinical exome sequencing: a comparative case study of Canadian provinces
Abstract Background As genome diagnostics advance, health systems face growing pressure to implement complex and resource-intensive technologies like exome sequencing (ES). Understanding how implementation varies across health systems is critical for informing the organization, delivery, and sustainability of advanced genome diagnostics. We explored how Canadian provincial health systems and key stakeholders have approached clinical ES implementation to guide ongoing efforts to improve access to genome diagnostics for Canadians. Methods Using an embedded multiple-case study design informed by Rogeres’ Diffusion of Innovation theory and the Consolidated Framework for Implementation Research, a comparative analysis was conducted to understand the provincial landscape of genetic service delivery and the implementation strategies used to support clinical ES in four Canadian provinces: Alberta, British Columbia, Manitoba, and Ontario. Semi-structured interviews with informants from clinical genetics, diagnostic laboratories, government and genomics research organizations were conducted between August 2023 and August 2024, and relevant documents published up to January 2026 were reviewed. Interview and document review data were integrated using qualitative thematic analysis. Results Forty-one participants were interviewed. Results revealed a shared provincial motivation to enhance local capacity for clinical ES, with an emphasis placed on the importance of centralized clinical ES infrastructure. A centralized implementation strategy appears to be essential to supporting the complexity of this intervention that requires significant resources (e.g., sequencing infrastructure, informatic, data storage), specialized expertise, and coordination among clinical and laboratory groups. Provincial differences in the delivery of genome diagnostics services were identified. These related primarily to the variable eligibility criteria across provinces, leading to inconsistencies in patient access to clinical ES. Conclusion Within the context of Canada’s decentralized health system, the findings emphasize the need for standardization of structures and processes to support the adoption, delivery, and ongoing evaluation of existing and emerging -omics technologies. Interprovincial collaboration and resource sharing may provide opportunities to strengthen implementation capacity and support access to genome diagnostics across Canada. These findings are also relevant to other countries with decentralized or regionally distributed health systems, where standardized approaches to the delivery of complex health interventions can facilitate improved access for patients.
Authors
- Mark Dobrow (ORCID: https://orcid.org/0000-0003-1105-1658)
- Robin Z. Hayeems (ORCID: https://orcid.org/0000-0003-3269-8004)
- Jan M. Friedman (ORCID: https://orcid.org/0000-0002-7482-9570)
- Christian R. Marshall (ORCID: https://orcid.org/0000-0002-4003-7671)
- Whiwon Lee (ORCID: https://orcid.org/0000-0002-4807-7782)
- Melanie Barwick
Institutions
- University of British Columbia (CA)
- University of Toronto (CA)
- Great Ormond Street Hospital (GB)
- Hospital for Sick Children (CA)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11148101/v1
- Primary Topic
- Genomics and Rare Diseases
- Type
- preprint
Funders
- Canadian Institutes of Health Research